Loss of bone density related to chemotherapy and adjuvant therapy for breast cancer can lead to debilitating hip and vertebral fractures. This discussion discusses the impact of resistance training for these patients.
Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk PatientsSeptember 19, 2016
Bioimpedance spectroscopy (BIS) effectively assesses for subclinical breast cancer-related lymphedema in patients at risk, and accurately assess patients for response to treatment.
Nurse researchers examined the validity, sensitivity, and specificity of various symptoms indicative of breast cancer-related lymphedema. They also determined the best cutoff points for diagnosing lymphedema and risk of lymphedema in breast cancer survivors.
Lymphedema related to breast cancer is one of the most distressing and feared late effects of breast cancer treatment. Given the improved survival following breast cancer, more and more survivors face lifetime risk of developing this late effect.
Lymphedema patients experienced a nearly 80% reduction in their cellulitis episodes just by using an advanced pneumatic compression device at home, according to a recent study.
Breast cancer survivors with a body mass index (BMI) >25 who report the use of tamoxifen therapy may be at increased risk for arm lymphedema.
Kinesio Tex Gold bandage proved to be safe and tolerable in patients with lymphedema, and resulted in improved functionality.
Home use of pneumatic compression devices to treat lymphedema can reduce annual treatment costs.
Advances in treatment offer insight into lymphedema management, improvements in care
A study from the University of Texas MD Anderson Cancer Center reveals a disparity in use of sentinel lymph node biopsy between black and white women.
Although they experienced classic symptoms of post-surgical lymphedema, many breast patients didn't recognize the condition as related to treatment.
Promoting lymph flow and optimizing BMI after breast cancer surgery had a 97% success rate for patients in the program 1 year after surgery, according to a new study.
Treatment-related dysphagia symptoms are likely caused by internal lymphedema among patients with head and neck cancer, according to research presented at the 2014 ASCO Annual Meeting.
Lymphedema can be accurately assessed through the use of Bioelectrical Impedance Analysis (BIA) ratios, according to a new study.
McMaster University researchers found no difference in patients with breast cancer who used simple compression bandages to treat lymphedema compared with those who underwent daily lymphatic massage.
Removal of all axillary lymph nodes may be unnecessary in women undergoing breast-conserving therapy (partial mastectomy followed by whole-breast radiation), researchers have found.
Breast cancer survivors who have extensive surgery are four times more likely to develop arm lymphedema, according to a new study.
Both axillary lymph node dissection and axillary radiotherapy provide excellent regional control for breast cancer patients with a positive sentinel node biopsy, according to a final study analysis.
Despite the low risk of lymphedema after sentinel lymph node biopsy, most women worry about this complication and practice risk-reducing behaviors to avoid it.
A set of proteins circulating in blood may flag the presence of lymphedema, which is difficult to diagnose before the onset of physical symptoms.
Lymphedema in patients with head and neck cancer can be described through an instrument that has been developed and validated.
Self-care is an essential part of treating patients with lymphedema, with full-body exercise and complete decongestive therapy being the best ways to minimize symptoms and maintain quality of life.
Emphasizing quality of life rather than focusing solely on reducing swelling appears to be key in managing cancer-related lymphedema.
Sentinel lymph node biopsy may be used in place of inguinal femoral lymphadenectomy.
In patients with a previous head and neck cancer, liposuction is a well-tolerated surgical treatment for persistent submental lymphedema.
Study finds that as BMI increases, there may be a threshold above which lymphatic flow is impaired.
After lymph node removal, painful swelling may result. This fact sheet educates patients about how to manage symptoms.
Six years after breast cancer treatment, more than 60% of women experienced at least one side effect amenable to rehabilitative intervention.
Researchers used a large data set to develop graphical statistical tools known as nomograms to help predict the 5-year risk of developing lymphedema after axillary dissection.
Having breast cancer can affect how you feel about yourself and your body. You also may experience difficult emotions. This patient fact sheet offers advice on how to cope with these issues.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|